This is a monitoring queue, not a trend leaderboard. A claim earns attention because it is consequential, checkable, and moving faster than the evidence.
Why it is on the radar: It combines two thin evidence records and turns a marketing nickname into a broad outcome promise.
Evidence trigger: Watch for a registered, controlled human combination trial with injury-specific outcomes.
Why it is on the radar: Biomarker findings are repeatedly converted into unmeasured body-composition and sleep outcomes.
Evidence trigger: Watch for direct human combination trials measuring those outcomes and adverse events.
Why it is on the radar: The claim conflicts with limitations in FDA-approved labeling and may be mistaken for a studied regimen.
Evidence trigger: Recheck current FDA labels and any direct randomized evidence.
Why it is on the radar: Separate ingredient findings are being used as evidence for an untested blend.
Evidence trigger: Watch for direct human combination evidence plus product identity and quality documentation.
Why it is on the radar: A clinical milestone is being collapsed into a regulatory decision.
Evidence trigger: The sponsor announced an NDA submission. Monitor official FDA records for an approval, complete response, final labeling, or other agency action.